Been quiet and busy but still here, still holding
Post# of 148280
I've been hearing that Brazil is highly impacted by variants, apparently including this newer Lambda version. I'm wondering if, and hoping we are, tracking the patients in the new trial(s) in Brazil to see who/how many may start with a variant and IF Leronlimab is having an impact in stopping it.
Just thinking about what a HUUUGE PR moment that could be if little CYDY can have a positive impact for the world in that regard. Appreciate any knowledge available on the Board.
To The Moon Alice